Century Therapeutics, Inc.(IPSC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPSC Century Therapeutics, Inc.

未开盘 05-07 16:00:00 EDT

2.31

-0.03

-1.28%

盘后2.27

-0.04-1.73%

18:40 EDT

最高2.37	最低2.21	成交量75.94万
今开2.37	昨收2.34	日振幅6.84%
总市值4.16亿	流通市值2.59亿	总股本1.80亿
成交额172.44万	换手率0.68%	流通股本1.12亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPSC","market":"US","secType":"STK","nameCN":"Century Therapeutics, Inc.","latestPrice":2.31,"timestamp":1778184000000,"preClose":2.34,"halted":0,"volume":759359,"hourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.31,"latestTime":"18:40 EDT","volume":5008,"amount":11477.017,"timestamp":1778193611444,"change":-0.04,"changeRate":-0.017316,"amplitude":0.017316},"delay":0,"changeRate":-0.012820512820512739,"floatShares":112000000,"shares":180000000,"eps":-0.110679,"marketStatus":"未开盘","change":-0.03,"latestTime":"05-07 16:00:00 EDT","open":2.37,"high":2.37,"low":2.21,"amount":1724441.2622029998,"amplitude":0.068376,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.110679,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1778227200000},"marketStatusCode":0,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":2.34,"preHourTrading":{"tag":"盘前","latestPrice":2.4293,"preClose":2.34,"latestTime":"09:14 EDT","volume":1023,"amount":2476.1390709,"timestamp":1778159695408,"change":0.0893,"changeRate":0.038162,"amplitude":0.07265},"postHourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.31,"latestTime":"18:40 EDT","volume":5008,"amount":11477.017,"timestamp":1778193611444,"change":-0.04,"changeRate":-0.017316,"amplitude":0.017316},"volumeRatio":1.28976,"impliedVol":0.3306,"impliedVolPercentile":0.14},"requestUrl":"/m/hq/s/IPSC/tweets","defaultTab":"tweets","newsList":[{"id":"1123383858","title":"更正：Century Therapeutics通过TD Cowen出售1,840万美元普通股——SEC文件披露（并非“拟融资1.5亿美元”）","url":"https://stock-news.laohu8.com/highlight/detail?id=1123383858","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123383858?lang=zh_cn&edition=full","pubTime":"2026-03-27 06:01","pubTimestamp":1774562495,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新文件披露，生物技术公司Century Therapeutics, Inc.已通过投资银行TD Cowen成功售出价值1,840万美元的普通股。市场观察人士指出，此次融资规模虽低于早期传闻，但仍反映出投资人对Century Therapeutics技术平台的认可。值得注意的是，此次SEC文件特别对融资金额进行了更正说明，强调实际完成金额为1,840万美元，而非部分媒体早前报道的1.5亿美元潜在融资计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4505","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142171978","title":"Century Therapeutics预计CNTY-813新药申请将于2026年第四季度提交，初步临床数据料在2027年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1142171978","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142171978?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:08","pubTimestamp":1773317305,"startTime":"0","endTime":"0","summary":"生物技术公司Century Therapeutics, Inc.宣布，其核心研发项目CNTY-813的新药临床试验申请（IND）预计将于2026年第四季度正式提交。若进展顺利，该项目首批临床数据有望在2027年下半年对外披露。\nCNTY-813作为公司创新细胞疗法管线的重要组成，其研发进展备受市场关注。此次明确的时间节点为投资者提供了可预期的研发里程碑，也反映出公司对项目推进的精准把控。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4539","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193588904","title":"Century Therapeutics提交招股说明书，拟由售股股东不时发售及转售最多1.761亿股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1193588904","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193588904?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:12","pubTimestamp":1770325967,"startTime":"0","endTime":"0","summary":"生物技术公司Century Therapeutics, Inc. (IPSC) 已正式向美国证券交易委员会提交招股说明书。根据文件披露，该公司计划由售股股东根据市场情况，在未来不定期地发售及转售最多1.761亿股普通股。此次股份发售的具体条款，包括发售价格和时间，将根据市场状况和公司需求而定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4505","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118926247","title":"世纪治疗公司任命杰出生物技术领袖韩李博士和马丁穆菲博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1118926247","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118926247?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:01","pubTimestamp":1765285278,"startTime":"0","endTime":"0","summary":"世纪治疗公司任命杰出生物技术领袖韩李博士和马丁穆菲博士为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4505","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102319451","title":"世纪疗法公司 - IND启用研究预计于2025年底启动，IND申请计划于2026年尽早提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1102319451","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102319451?lang=zh_cn&edition=full","pubTime":"2025-11-13 20:05","pubTimestamp":1763035503,"startTime":"0","endTime":"0","summary":"世纪疗法公司 - IND启用研究预计于2025年底启动，IND申请计划于2026年尽早提交","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPSC","BK4139","BK4505","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518057042","title":"Century Therapeutics, Inc.盘中异动 下午盘股价大跌5.37%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518057042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518057042?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:09","pubTimestamp":1741626557,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时09分，Century Therapeutics, Inc.股票出现异动，股价大幅下挫5.37%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为4221.02%、3807.16%、983.02%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为88.14%、78.32%、58.34%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010918964061c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010918964061c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IPSC","BK4539","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517294596","title":"Century Therapeutics, Inc.盘中异动 急速拉升5.07%报0.636美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294596?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:54","pubTimestamp":1741186489,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时54分，Century Therapeutics, Inc.股票出现异动，股价快速上涨5.07%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305225450989d4b17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305225450989d4b17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4505","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516658770","title":"Century Therapeutics, Inc.盘中异动 快速下跌5.98%报0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658770?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:00","pubTimestamp":1741017628,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时00分，Century Therapeutics, Inc.股票出现异动，股价急速下挫5.98%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3045.66%、143.00%、135.74%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040000289637c2a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040000289637c2a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4539","LENZ","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514713320","title":"Century Therapeutics, Inc.盘中异动 快速下跌6.10%报0.632美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514713320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514713320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:37","pubTimestamp":1740753440,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时37分，Century Therapeutics, Inc.股票出现异动，股价急速下挫6.10%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822372198967b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822372198967b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IPSC","BK4139","LENZ","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513778610","title":"Century Therapeutics, Inc.盘中异动 急速下跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778610?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:04","pubTimestamp":1740409487,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时04分，Century Therapeutics, Inc.股票出现异动，股价快速下挫5.49%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为160.43%、70.71%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230449a2521cc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230449a2521cc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPSC","BK4539","BK4505","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169253","title":"Century Therapeutics, Inc.盘中异动 早盘股价大涨5.66%报0.818美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169253?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:17","pubTimestamp":1739891861,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时17分，Century Therapeutics, Inc.股票出现波动，股价急速上涨5.66%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231741a24ab736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231741a24ab736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPSC","BK4505","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696263","title":"Century Therapeutics, Inc.盘中异动 大幅拉升5.60%报0.796美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696263?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:37","pubTimestamp":1739543828,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时37分，Century Therapeutics, Inc.股票出现波动，股价大幅拉升5.60%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cns Pharmaceuticals, Inc.、Moleculin Biotech, Inc.、Os Therapies Incorporated涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1266.28%、383.31%、373.53%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为49.61%、31.08%、20.20%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422370998858ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422370998858ac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","IPSC","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333380","title":"Century Therapeutics, Inc.盘中异动 大幅下挫5.65%报0.681美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510333380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:37","pubTimestamp":1739284645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时37分，Century Therapeutics, Inc.股票出现波动，股价大幅跳水5.65%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2150.85%、553.12%、206.49%，振幅较大的相关个股有In8Bio, Inc.、Dominari Holdings Inc.、Ocean Biomedical, Inc.，振幅分别为31.80%、25.49%、22.23%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223726abcb077e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223726abcb077e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4539","IPSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509278552","title":"Century Therapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509278552?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:04","pubTimestamp":1738872270,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时04分，Century Therapeutics, Inc.股票出现异动，股价快速跳水5.23%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207040430abc51553&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207040430abc51553&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","IPSC","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508579194","title":"Century Therapeutics, Inc.盘中异动 早盘急速拉升6.50%报0.831美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508579194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508579194?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:37","pubTimestamp":1738679825,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时37分，Century Therapeutics, Inc.股票出现异动，股价大幅上涨6.50%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1007.26%、715.50%、190.95%，振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为35.91%、21.70%、21.03%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223705abc22979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223705abc22979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPSC","BK4505","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149175","title":"Century Therapeutics, Inc.盘中异动 股价大跌6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149175?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:44","pubTimestamp":1738593875,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时44分，Century Therapeutics, Inc.股票出现波动，股价快速下挫6.96%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为406.01%、345.36%、186.32%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.，振幅分别为82.67%、50.76%、35.62%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322443598797155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322443598797155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4539","LENZ","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507627987","title":"Century Therapeutics, Inc.盘中异动 大幅跳水5.23%报0.781美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507627987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507627987?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:30","pubTimestamp":1738251010,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时30分，Century Therapeutics, Inc.股票出现异动，股价快速跳水5.23%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302330109614448b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302330109614448b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","IPSC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507545056","title":"Century Therapeutics, Inc.盘中异动 临近午盘急速下挫5.12%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507545056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507545056?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:53","pubTimestamp":1738083219,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时53分，Century Therapeutics, Inc.股票出现波动，股价急速下挫5.12%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129005339a2328b94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129005339a2328b94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPSC","BK4505","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045960","title":"Century Therapeutics, Inc.盘中异动 快速拉升5.36%报0.939美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505045960?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:29","pubTimestamp":1737649799,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时29分，Century Therapeutics, Inc.股票出现波动，股价大幅拉升5.36%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Nutriband Inc C/Wts 、Exicure, Inc.、Nutriband Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Vigil Neuroscience, Inc.较为活跃，换手率分别为3581.20%、654.48%、57.71%，振幅较大的相关个股有Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为64.29%、55.57%、54.22%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003000960e5b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003000960e5b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","LENZ","BK4139","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503190969","title":"Century Therapeutics, Inc.盘中异动 早盘股价大跌5.52%报0.890美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503190969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503190969?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:41","pubTimestamp":1737042063,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时41分，Century Therapeutics, Inc.股票出现异动，股价急速下挫5.52%。截至发稿，该股报0.890美元/股，成交量8.3318万股，换手率0.10%，振幅6.16%。Century Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Century Therapeutics, Inc.公司简介：Century Therapeutics Inc 是一家生物技术公司，专门利用成人干细胞开发针对癌症，自身免疫和炎症性疾病的先进细胞疗法产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116234103abad603e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116234103abad603e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IPSC","BK4539","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.centurytx.com","stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0221},{"period":"3month","weight":0.3588},{"period":"6month","weight":3.3194},{"period":"1year","weight":3.427},{"period":"ytd","weight":1.3221}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Century Therapeutics, Inc.于2018年3月5日在特拉华州注册成立。该公司是一家专注于开发用于自身免疫性疾病和癌症的异体多能干细胞疗法的生物技术公司。其平台利用诱导多能干细胞生成多种细胞类型，包括胰岛β细胞和免疫细胞，并通过专有技术进行工程化改造以防止宿主免疫排斥。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.144813},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004102},{"month":3,"riseRate":0.2,"avgChangeRate":-0.105492},{"month":4,"riseRate":0.4,"avgChangeRate":-0.059199},{"month":5,"riseRate":0.6,"avgChangeRate":-0.050478},{"month":6,"riseRate":0.25,"avgChangeRate":-0.03193},{"month":7,"riseRate":0.2,"avgChangeRate":0.014338},{"month":8,"riseRate":0,"avgChangeRate":-0.130737},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050903},{"month":10,"riseRate":0.4,"avgChangeRate":-0.087368},{"month":11,"riseRate":0.2,"avgChangeRate":0.035344},{"month":12,"riseRate":0.4,"avgChangeRate":0.230677}],"exchange":"NASDAQ","name":"Century Therapeutics, Inc.","nameEN":"Century Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Century Therapeutics, Inc.(IPSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Century Therapeutics, Inc.(IPSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Century Therapeutics, Inc.,IPSC,Century Therapeutics, Inc.股票,Century Therapeutics, Inc.股票老虎,Century Therapeutics, Inc.股票老虎国际,Century Therapeutics, Inc.行情,Century Therapeutics, Inc.股票行情,Century Therapeutics, Inc.股价,Century Therapeutics, Inc.股市,Century Therapeutics, Inc.股票价格,Century Therapeutics, Inc.股票交易,Century Therapeutics, Inc.股票购买,Century Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Century Therapeutics, Inc.(IPSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Century Therapeutics, Inc.(IPSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}